[Dose optimization of anticancer drugs in the elderly]
1Dept. of Clinical Pharmacokinetics and Pharmacodynamics, School of Medicine, Keio University.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|January 19, 2015
Summary
Cancer treatment for elderly patients needs careful assessment due to age-related changes affecting drug response. Dose adjustments based on creatinine clearance (Ccr) and close monitoring for neutropenia are crucial for safe and effective therapy.
Area of Science:
- Geriatric oncology
- Clinical pharmacology
- Pharmacokinetics and pharmacodynamics
Context:
- Elderly cancer patients exhibit significant interpatient variability in physiological functions.
- Age-related changes impact drug absorption, distribution, metabolism, and excretion.
- Standard pharmacokinetic and pharmacodynamic assessments may not fully capture individual patient responses.
Purpose:
- To highlight the necessity of comprehensive patient assessment before initiating cancer therapy in the elderly.
- To emphasize the importance of accurate renal function evaluation for dose optimization.
- To underscore the need for vigilant monitoring of adverse events, particularly neutropenia.
Summary:
- Age-related physiological changes necessitate individualized cancer treatment strategies in elderly patients.
- Accurate assessment of renal function, preferably using creatinine clearance (Ccr) calculated via the Cockcroft-Gault equation, is vital for drug dosing.
- Elderly individuals may be more susceptible to cytotoxic agent-induced neutropenia, requiring close monitoring and prompt tolerability assessments after each treatment cycle.
Impact:
- Optimized dosing and vigilant monitoring can improve treatment efficacy and reduce toxicity in elderly cancer patients.
- This approach supports safer and more effective cancer care tailored to the unique needs of geriatric populations.
- Facilitates better clinical decision-making for oncologists and pharmacists managing cancer in older adults.
More Related Videos
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
13.0K
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
7.9K
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
375
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
375
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
359
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
359
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
370
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
370
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
346
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
346
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
334
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
334
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
828
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
828